Showing 401 - 420 results of 5,248 for search '"Vascular endothelial growth factor"', query time: 0.22s Refine Results
  1. 401

    Relationship between Macular Thickness and the Ratio of Vascular Endothelial Growth Factor to Its Soluble Receptor 1 in Non-Proliferative Diabetic Retinopathy by Zahra Hasanpour, Shaghayegh Haghjooy Javanmard, Zahra Abbaspoor, Gholam Ali Naderian, Mehdi Jahanmard

    Published 2012-11-01
    “…Background: The goal of this study was to determine the ratio of vascular endothelial growth factor (VEGF) to soluble VEGF receptor 1 (SVEGFR1) in aqueous humor of patients with non-proliferative diabetic retinopathy (NPDR). …”
    Get full text
    Article
  2. 402
  3. 403
  4. 404

    Pancreatic endoplasmic reticulum kinase activation promotes medulloblastoma cell migration and invasion through induction of vascular endothelial growth factor A. by Stephanie Jamison, Yifeng Lin, Wensheng Lin

    Published 2015-01-01
    “…Evidence is accumulating that activation of the pancreatic endoplasmic reticulum kinase (PERK) in response to endoplasmic reticulum (ER) stress adapts tumor cells to the tumor microenvironment and enhances tumor angiogenesis by inducing vascular endothelial growth factor A (VEGF-A). Recent studies suggest that VEGF-A can act directly on certain tumor cell types in an autocrine manner, via binding to VEGF receptor 2 (VEGFR2), to promote tumor cell migration and invasion. …”
    Get full text
    Article
  5. 405
  6. 406

    The Antiangiogenic Effects of a Vascular Endothelial Growth Factor Decoy Receptor Can Be Monitored in Vivo Using Contrast-Enhanced Ultrasound Imaging by Flemming Forsberg, Raymond J. Ro, Andrew Marshall, Ji-Bin Liu, See-Ying Chiou, Daniel A. Merton, Priscilla Machado, Adam P. Dicker, Levon N. Nazarian

    Published 2014-03-01
    “…We investigated whether the effects of a vascular endothelial growth factor decoy receptor (VEGF Trap, Regeneron Pharmaceuticals, Tarrytown, NY) could be monitored in vivo using contrast-enhanced ultrasonography (CEUS). …”
    Get full text
    Article
  7. 407
  8. 408
  9. 409

    Т786С POLYMORPHISM IN THE ENDOTHELIAL NO SYNTHASE GENE, VASCULAR ENDOTHELIAL GROWTH FACTOR-А IN MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION by O. V. Petyunina, M. P. Kopytsya, L. L. Pietienova

    Published 2019-03-01
    “…To investigate associations of polymorphism Т786С in the eNOS gene with clinical and anamnestic data in patients with ST-segment elevation myocardial infarction (STEMI), the level of vascular endothelial growth factor-A (VEGF-А), clinical course and prognosis of disease. …”
    Get full text
    Article
  10. 410

    Influence of genistein and diadizine on regularity of estrous cycle in cyclic female Wistar rat: interaction with estradiol receptors and vascular endothelial growth factor by Doaa Elsayed, seham Helmy, Amina Dessouki, Amal El-Nahla, Heba Abdelrazek, Heba Gad El-Hak

    Published 2022-10-01
    “…Abstract Background: The study was planned to explain the interactions of isoflavones with estrogen receptors alpha (ERα), beta (ERβ) and vascular endothelial growth factor (VEGF) expressions in ovarian and uterine tissues during different stages of estrous cycle of regular cyclic female Wistar rats. …”
    Get full text
    Article
  11. 411
  12. 412
  13. 413
  14. 414

    The Effect of Resistance Training Program with Citrulline-Malate on Blood Pressure, Nitric Oxide, and Vascular Endothelial Growth Factor in Postmenopausal Women with Prehypertension by naser behpoor, fardin moradi, Vahid tadibi

    Published 2020-04-01
    “…The present study aims at investigating the effect of eight-week resistance training with citrulline-malate consumption on blood pressure, Nitric Oxide (NO), and Vascular Endothelial Growth Factor (VEGF) in postmenopausal women with prehypertension Materials & Methods: The sample population is postmenopausal women with pre-hypertensive age ranging from 50 to 55 years old divided randomly into six groups, including “training + supplement”, “training + placebo”, “training”, “no training + supplement”, “supplement” and “placebo”. …”
    Get full text
    Article
  15. 415

    Response to Initial Anti-Vascular Endothelial Growth Factor for Diabetic Macular Edema Is Significantly Correlated with Response to Third Consecutive Monthly Injection by Satoshi Maeda, Masahiko Sugimoto, Yumiho Tenma, Hideyuki Tsukitome, Kumiko Kato, Shinichiro Chujo, Yoshitsugu Matsui, Hisashi Matsubara, Mineo Kondo

    Published 2022-10-01
    “…Purpose: To determine whether the response to the initial anti-vascular endothelial growth factor (anti-VEGF) injection to treat diabetic macular edema (DME) is significantly correlated with the response to the third consecutive monthly injection of the same anti-VEGF agent. …”
    Get full text
    Article
  16. 416
  17. 417

    Serum Vitamin D Levels and Vascular Endothelial Growth Factor in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Study by Shilpa K Shet, Aruna Gowdra, HL Vishwanath, K Ravi

    Published 2024-03-01
    “…Recent research has demonstrated that low Vitamin D levels and high Vascular Endothelial Growth Factor (VEGF) in middle-aged and elderly populations represent a risk factor for Type 2 Diabetes Mellitus (T2DM). …”
    Get full text
    Article
  18. 418
  19. 419
  20. 420